Skip to main content

Table 2 Characteristics of JIA patients from the Oklahoma cohort

From: Whole blood expression profiling from the TREAT trial: insights for the pathogenesis of polyarticular juvenile idiopathic arthritis

Patient number

Age

Sex

RF status

ANA status

1

9 years

F

Negative

Negative

2

12 years

F

Negative

Negative

3

9 years

M

Negative

Negative

4

11 years

F

Negative

Positive

5

7 years

F

Negative

Negative

6

3 years

F

Negative

Positive

7

8 years

M

Negative

Negative

8

14 years

M

Negative

Negative

9

15 years

F

Negative

Positive

10

4 years

M

Negative

Negative

  1. ANA Antinuclear antibody, F female, JIA juvenile idiopathic arthritis, M male, RF rheumatoid factor